SEARCH

SEARCH BY CITATION

References

  • Au, W.Y., Lie, A.K., Liang, R., Kwong, Y.L., Yau, C.C., Cheung, M.M., Ngan, K.C., Lau, W.H., Wong, K.H., Yiu, H.Y., Cheng, H.C., Au, K.H. & Chan, J.K. (2003) Autologous stem cell transplantation for nasal NK/T-cell lymphoma: a progress report on its value. Annals of Oncology, 14, 16731676.
  • Bearman, S.I., Appelbaum, F.R., Buckner, C.D., Petersen, F.B., Fisher, L.D., Clift, R.A. & Thomas, E.D. (1988) Regimen-related toxicity in patients undergoing bone marrow transplantation. Journal of Clinical Oncology, 6, 15621568.
  • Bishop, M.R. (2003) The graft-versus-lymphoma effect: fact, fiction, or opportunity? Journal of Clinical Oncology, 21, 37133715.
  • Chan, J.K., Sin, V.C., Wong, K.F., Ng, C.S., Tsang, W.Y., Chan, C.H., Cheung, M.M. & Lau, W.H. (1997) Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood, 89, 45014513.
  • Chan, J., Jaffe, E. & Ralfkiaer, E. (2001a) Blastic NK-cell lymphoma. In: World Health Organization Classification of Tumours (ed. by E.Jaffe, N.Harris, H.Stein & J.Vardiman). IARC Press, Lyon.
  • Chan, J., Jaffe, E. & Ralfkiaer, E. (2001b) Extranodal NK/T-cell lymphoma, nasal type. In: World Health Organization Classification of Tumours (ed. by E.Jaffe, N.Harris, H.Stein & J.Vardiman). IARC Press, Lyon.
  • Chan, J., Wong, K., Jaffe, E. & Ralfkiaer, E. (2001c) Aggressive NK-cell leukaemia. In: World Health Organization Classification of Tumours (ed. by E.Jaffe, N.Harris, H.Stein & J.Vardiman). IARC Press, Lyon.
  • Cheung, M.M., Chan, J.K., Lau, W.H., Foo, W., Chan, P.T., Ng, C.S. & Ngan, R.K. (1998) Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. Journal of Clinical Oncology, 16, 7077.
  • Chim, C.S., Ma, S.Y., Au, W.Y., Choy, C., Lie, A.K., Liang, R., Yau, C.C. & Kwong, Y.L. (2004) Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood, 103, 216221.
  • Clift, R.A., Buckner, C.D., Appelbaum, F.R., Bearman, S.I., Petersen, F.B., Fisher, L.D., Anasetti, C., Beatty, P., Bensinger, W.I., Doney, K., Hill, R.S., McDonald, G.B., Martin, P., Sanders, J., Singer, J., Stewart, P., Sullivan, K.M., Witherspoon, R., Storb, R., Hansen, J.A. & Thomas, E.D. (1990) Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. Blood, 76, 18671871.
  • Dominietto, A., Lamparelli, T., Raiola, A.M., Van Lint, M.T., Gualandi, F., Berisso, G., Bregante, S., Di Grazia, C., Soracco, M., Pitto, A., Frassoni, F. & Bacigalupo, A. (2002) Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation. Blood, 100, 39303934.
  • Giralt, S., Estey, E., Albitar, M., van Besien, K., Rondon, G., Anderlini, P., O'Brien, S., Khouri, I., Gajewski, J., Mehra, R., Claxton, D., Andersson, B., Beran, M., Przepiorka, D., Koller, C., Kornblau, S., Korbling, M., Keating, M., Kantarjian, H. & Champlin, R. (1997) Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood, 89, 45314536.
  • Imashuku, S., Hibi, S., Todo, S., Sako, M., Inoue, M., Kawa, K., Koike, K., Iwai, A., Tsuchiya, S., Akiyama, Y., Kotani, T., Kawamura, Y., Hirosawa, M., Hasegawa, D., Kosaka, Y., Yamaguchi, H., Ishii, E., Kato, K., Ishii, M. & Kigasawa, H. (1999) Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan. Bone Marrow Transplantation, 23, 569572.
  • Izutsu, K., Kanda, Y., Ohno, H., Sao, H., Ogawa, H., Miyazaki, Y., Kawa, K., Kodera, Y., Kato, S., Morishima, Y. & Hirai, H. (2004) Unrelated bone marrow transplantation for non-Hodgkin lymphoma: a study from the Japan Marrow Donor Program. Blood, 103, 19551960.
  • Jaffe, E.S., Chan, J.K., Su, I.J., Frizzera, G., Mori, S., Feller, A.C. & Ho, F.C. (1996) Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology. American Journal of Surgical Pathology, 20, 103111.
  • Jones, R.J., Ambinder, R.F., Piantadosi, S. & Santos, G.W. (1991) Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood, 77, 649653.
  • Kim, K., Kim, W.S., Jung, C.W., Im, Y.H., Kang, W.K., Lee, M.H., Park, C.H., Ko, Y.H., Ree, H.J. & Park, K. (2002) Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma (REAL) classification. European Journal of Cancer, 38, 7581.
  • Kwong, Y.L., Chan, A.C., Liang, R., Chiang, A.K., Chim, C.S., Chan, T.K., Todd, D. & Ho, F.C. (1997) CD56+ NK lymphomas: clinicopathological features and prognosis. British Journal of Haematology, 97, 821829.
  • Li, C.C., Tien, H.F., Tang, J.L., Yao, M., Chen, Y.C., Su, I.J., Hsu, S.M. & Hong, R.L. (2004) Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer, 100, 366375.
  • Nakamura, S., Katoh, E., Koshikawa, T., Yatabe, Y., Nagasaka, T., Ishida, H., Tokoro, Y., Koike, K., Kagami, Y., Ogura, M., Kojima, M., Nara, Y., Mizoguchi, Y., Hara, K., Kurita, S., Seto, M. & Suchi, T. (1997) Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese. Pathology International, 47, 3853.
  • Oshimi, K. (2003) Leukemia and lymphoma of natural killer lineage cells. International Journal of Hematology, 78, 1823.
  • Ratanatharathorn, V., Uberti, J., Karanes, C., Abella, E., Lum, L.G., Momin, F., Cummings, G. & Sensenbrenner, L.L. (1994) Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. Blood, 84, 10501055.
  • Saito, T., Kanda, Y., Kami, M., Kato, K., Shoji, N., Kanai, S., Ohnishi, T., Kawano, Y., Nakai, K., Ogasawara, T., Matsubara, H., Makimoto, A., Tanosaki, R., Tobinai, K., Wakasugi, H., Takaue, Y. & Mineishi, S. (2002) Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma. Clinical Cancer Research, 8, 10141020.
  • Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varadi, G., Kirschbaum, M., Ackerstein, A., Samuel, S., Amar, A., Brautbar, C., Ben-Tal, O., Eldor, A. & Or, R. (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood, 91, 756763.
  • Song, S.Y., Kim, W.S., Ko, Y.H., Kim, K., Lee, M.H. & Park, K. (2002) Aggressive natural killer cell leukemia: clinical features and treatment outcome. Haematologica, 87, 13431345.
  • Suzuki, R., Suzumiya, J., Nakamura, S., Aoki, S., Notoya, A., Ozaki, S., Gondo, H., Hino, N., Mori, H., Sugimori, H., Kawa, K. & Oshimi, K. (2004) Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia, 18, 763770.
  • Suzuki, R., Nakamura, S., Suzumiya, J., Ichimura, K., Ichikawa, M., Ogata, K., Kura, Y., Aikawa, K., Teshima, H., Sako, M., Kojima, H., Nishio, M., Yoshino, T., Sugimori, H., Kawa, K., Oshimi, K. & the NK-cell Tumor Study Group. (2005) Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement. Cancer (Epub ahead of print).
  • Takenaka, K., Shinagawa, K., Maeda, Y., Makita, M., Kozuka, T., Ashiba, A., Yamamoto, K., Fujii, N., Nawa, Y., Hiramatsu, Y., Sunami, K., Ishimaru, F., Yoshimo, T., Kiura, K. & Harada, M. (2001) High-dose chemotherapy with hematopoietic stem cell transplantation is effective for nasal and nasal-type CD56+ natural killer cell lymphomas. Leukemia and Lymphoma, 42, 12971303.
  • Tanimoto, T.E., Kusumi, E., Hamaki, T., Yuji, K., Ueyama, J., Miyakoshi, S., Morinaga, S., Kami, M., Kanda, Y., Ando, T., Yoshihara, S., Masuo, S., Kim, S.W., Nakai, K., Tobinai, K., Tanosaki, R., Mineishi, S., Takaue, Y. & Muto, Y. (2003) High complete response rate after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in advanced malignant lymphoma. Bone Marrow Transplantation, 32, 131137.